Publication: The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis
dc.contributor.author | Carmona, F David | |
dc.contributor.author | Martín, José-Ezequiel | |
dc.contributor.author | Beretta, Lorenzo | |
dc.contributor.author | Simeón, Carmen P | |
dc.contributor.author | Carreira, Patricia E | |
dc.contributor.author | Callejas, José Luis | |
dc.contributor.author | Fernández-Castro, Mónica | |
dc.contributor.author | Sáez-Comet, Luis | |
dc.contributor.author | Beltrán, Emma | |
dc.contributor.author | Camps, María Teresa | |
dc.contributor.author | Egurbide, María Victoria | |
dc.contributor.author | Airó, Paolo | |
dc.contributor.author | Scorza, Raffaella | |
dc.contributor.author | Lunardi, Claudio | |
dc.contributor.author | Hunzelmann, Nicolas | |
dc.contributor.author | Riemekasten, Gabriela | |
dc.contributor.author | Witte, Torsten | |
dc.contributor.author | Kreuter, Alexander | |
dc.contributor.author | Distler, Jörg H W | |
dc.contributor.author | Madhok, Rajan | |
dc.contributor.author | Shiels, Paul | |
dc.contributor.author | van Laar, Jacob M | |
dc.contributor.author | Fonseca, Carmen | |
dc.contributor.author | Denton, Christopher | |
dc.contributor.author | Herrick, Ariane | |
dc.contributor.author | Worthington, Jane | |
dc.contributor.author | Schuerwegh, Annemie J | |
dc.contributor.author | Vonk, Madelon C | |
dc.contributor.author | Voskuyl, Alexandre E | |
dc.contributor.author | Radstake, Timothy R D J | |
dc.contributor.author | Martín, Javier | |
dc.contributor.authoraffiliation | [Carmona,FD; Martín JE] Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain. [ Beretta,L; Scorza,R] Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, University of Milan, Italy. [ Carmen,P S] Department of Internal Medicine, Hospital Vall d’Hebron, Barcelona, Spain. [Carreira,P E] Department of Rheumatology, Hospital 12 de Octubre, Madrid, Spain. [Callejas,J.L. ] Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, Spain. [Fernández-Castro,M.] Department of Rheumatology, Hospital Puerta de Hierro Majadahonda, Madrid, Spain. [Sáez-Comet,L] Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain. [Beltran,E.] Department of Rheumatology, Hospital General Universitario de Valencia, Spain. [Camps,MT.] Department of Internal Medicine, Hospital Carlos Haya, Málaga, Spain. [Egurbide,M.V.] Department of Internal Medicine, Hospital de Cruces, Barakaldo, Spain. [Airo,P.] Servizio di Reumatologia ed Immunologia Clinica Spedali Civili, Brescia, Italy. [Lunardi,C] Department of Medicine, Universita` degli Studi di Verona, Verona, Italy. [Hunzelmann, N] Department of Dermatology, University of Cologne, Cologne, Germany. [Riemekasten,G] Department of Rheumatology and Clinical Immunology, Charite´ University Hospital, Berlin, Germany. [Witte,T] Hannover Medical School, Hannover, Germany. [Kreuter,A] Ruhr University of Bochum, Germany. [Distler,JHW] Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany. [Madhok,R; Shiels,P] Centre for Rheumatic Diseases, Glasgow Royal Infirmary, University of Glasgow, United Kingdom. [Van Laar,JM] Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom. [Fonseca,C; Denton,C] Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom. [Herrick,A; Worthington, J] Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom. [Schuerwegh,AJ] Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. [Vonk,MC; Radstake,T.R.D] Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. [Voskuyl,AE] Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands. [Radstake,T.R.D] Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherland. | es |
dc.contributor.funder | 17552, Arthritis Research UK, United Kingdom; | |
dc.contributor.group | The Spanish Scleroderma Group | es |
dc.date.accessioned | 2015-08-04T12:37:31Z | |
dc.date.available | 2015-08-04T12:37:31Z | |
dc.date.issued | 2013-08 | |
dc.description | Journal Article; Research Support, Non-U.S. Gov't; | es |
dc.description.abstract | Systemic sclerosis (SSc) is a fibrotic autoimmune disease in which the genetic component plays an important role. One of the strongest SSc association signals outside the human leukocyte antigen (HLA) region corresponds to interferon (IFN) regulatory factor 5 (IRF5), a major regulator of the type I IFN pathway. In this study we aimed to evaluate whether three different haplotypic blocks within this locus, which have been shown to alter the protein function influencing systemic lupus erythematosus (SLE) susceptibility, are involved in SSc susceptibility and clinical phenotypes. For that purpose, we genotyped one representative single-nucleotide polymorphism (SNP) of each block (rs10488631, rs2004640, and rs4728142) in a total of 3,361 SSc patients and 4,012 unaffected controls of Caucasian origin from Spain, Germany, The Netherlands, Italy and United Kingdom. A meta-analysis of the allele frequencies was performed to analyse the overall effect of these IRF5 genetic variants on SSc. Allelic combination and dependency tests were also carried out. The three SNPs showed strong associations with the global disease (rs4728142: P = 1.34×10(-8), OR = 1.22, CI 95% = 1.14-1.30; rs2004640: P = 4.60×10(-7), OR = 0.84, CI 95% = 0.78-0.90; rs10488631: P = 7.53×10(-20), OR = 1.63, CI 95% = 1.47-1.81). However, the association of rs2004640 with SSc was not independent of rs4728142 (conditioned P = 0.598). The haplotype containing the risk alleles (rs4728142*A-rs2004640*T-rs10488631*C: P = 9.04×10(-22), OR = 1.75, CI 95% = 1.56-1.97) better explained the observed association (likelihood P-value = 1.48×10(-4)), suggesting an additive effect of the three haplotypic blocks. No statistical significance was observed in the comparisons amongst SSc patients with and without the main clinical characteristics. Our data clearly indicate that the SLE risk haplotype also influences SSc predisposition, and that this association is not sub-phenotype-specific. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Carmona FD, Martín JE, Beretta L, Simeón CP, Carreira PE, Callejas JL, et al. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS ONE. 2013; 8(1):e54419 | es |
dc.identifier.doi | 10.1371/journal.pone.0054419 | |
dc.identifier.essn | 1932-6203 | |
dc.identifier.pmc | PMC3553151 | |
dc.identifier.pmid | 23372721 | |
dc.identifier.uri | http://hdl.handle.net/10668/1942 | |
dc.journal.title | PloS one | |
dc.language.iso | en | |
dc.publisher | Public Library of Science | es |
dc.relation.publisherversion | http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054419 | es |
dc.rights.accessRights | open access | |
dc.subject | Factores reguladores del interferón | es |
dc.subject | Predisposición genética a la enfermedad | es |
dc.subject | Haplotipos | es |
dc.subject | Polimorfismo de nucleótido simple | es |
dc.subject | Lupus eritematoso sistémico | es |
dc.subject | Desequilibrio de ligamiento | es |
dc.subject | Grupo de ascendencia continental europea | es |
dc.subject | Factores de riesgo | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Population Groups::Continental Population Groups::European Continental Ancestry Group | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Female | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Gene Frequency | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genetic Loci | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype::Genetic Predisposition to Disease | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype::Haplotypes | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intracellular Signaling Peptides and Proteins::Adaptor Proteins, Signal Transducing::Interferon Regulatory Factors | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Linkage::Linkage Disequilibrium | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Immune System Diseases::Autoimmune Diseases::Lupus Erythematosus, Systemic | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Male | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Phenotype | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Polymorphism, Genetic | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Factors::Causality::Risk Factors | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Scleroderma, Systemic | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Alleles | es |
dc.title | The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Carmona_TheSystemicLupus.pdf
- Size:
- 158.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado